Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

SWX/ZBH stock hub

SWX/ZBH has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SWX/ZBHis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

12.4B

SIX Swiss Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SWX/ZBH

In the news

Latest news · SWX/ZBH

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E9.7

P25 15.9P50 20.7P75 33.1

Trailing P/E20.3

P25 19.6P50 21.4P75 37.6

ROE6.1

P25 -6.1P50 7.9P75 17

ROIC6.2

P25 -4.4P50 6.6P75 15.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SWX/ZBH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

232

Groups with data

Currency

USD

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	CH
Employees	17,000
Employees Change	-1,000%
Employees Change Percent	-5.56
Enterprise value	CHF 17.9B
Exchange	SIX Swiss Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical Devices
Isin	US98956P1021
Last refreshed	2026-05-10
Market cap	CHF 12.4B
Price	CHF 65
Price currency	CHF
Rev Per Employee	396,771.02x
Sector	Healthcare
Sic	3842
Symbol	swx/ZBH
Website	https://www.zimmerbiomet.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.93%
EV Earnings	29.35x
EV/EBIT	15.66x
EV/EBITDA	8.71x
EV/FCF	19.6x
EV/Sales	2.74x
FCF yield	7.38%
Forward P/E	9.69x
P/B ratio	1.22x
P/E ratio	20.28x
P/S ratio	1.84x
PE Ratio10 Y	64.65x
PE Ratio3 Y	28.98x
PE Ratio5 Y	48.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.5%
EBITDA Margin	30.69%
FCF margin	13.55%
Gross margin	70.18%
Gross Profit	CHF 4.7B
Gross Profit Growth	7.66%
Gross Profit Growth Q	12.01%
Gross Profit Growth3 Y	5.07%
Gross Profit Growth5 Y	4.14%
Net Income	CHF 610.6M
Net Income Growth	-16.66%
Net Income Growth Q	30.82%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	19.18%
Net Income Growth5 Y	6.04%
Pretax Margin	10.74%
Profit Margin	9.05%
Profit Per Employee	CHF 35,916
Profitable Years	5
ROA	4.1
Roa5y	3.96
ROCE	7.41
ROE	6.06
Roe5y	5.43
ROIC	6.24
Roic5y	6.45

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-4.2%
Cagr15y	1.66%
Cagr1y	-39.82%
Cagr20y	0.05%
Cagr3y	-15.36%
Cagr5y	-14.94%
Div CAGR10	1.42%
Div CAGR3	-5.53%
Div CAGR5	-2.91%
EPS Growth	-14.45
EPS Growth Q	34.07
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	21.69
EPS Growth5 Y	7.16
FCF Growth	-8.32%
FCF Growth Q	-11.71%
FCF Growth3 Y	9.32%
FCF Growth5 Y	12.99%
OCF Growth	1.18%
OCF Growth Q	-6.11%
OCF Growth10 Y	4.96%
OCF Growth3 Y	7.29%
OCF Growth5 Y	10.85%
Revenue Growth	9.23x
Revenue Growth Q	9.3x
Revenue Growth Quarters	14x
Revenue Growth Years	4x
Revenue Growth3 Y	5.76x
Revenue Growth5 Y	4.21x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 0.37
Assets	CHF 18.2B
Cash	CHF 383.8M
Current Assets	CHF 3.9B
Current Liabilities	CHF 2.2B
Debt	CHF 6.1B
Debt EBITDA	CHF 2.87
Debt Equity	CHF 0.6
Debt FCF	CHF 6.66
Equity	CHF 10.2B
Interest Coverage	4.98
Liabilities	CHF 8.1B
Long Term Assets	CHF 14.4B
Long Term Liabilities	CHF 5.8B
Net Cash	CHF -5.7B
Net Cash By Market Cap	CHF -46.04
Net Debt EBITDA	CHF 2.75
Net Debt Equity	CHF 0.56
Net Debt FCF	CHF 6.24
Tangible Book Value	CHF -1.4B
Tangible Book Value Per Share	CHF -7.49
WACC	7.66

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.73
Inventory Turnover	1.12
Net Working Capital	CHF 2.2B
Quick ratio	0.77
Working Capital	CHF 1.7B
Working Capital Turnover	CHF 2.5

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.25%
Dividend Growth	-9.26%
Dividend Growth Years	0%
Dividend per share	CHF 0.77
Dividend Years	15
Dividend Yield	1.18%
Ex Div Date	2026-03-31
Last Dividend	CHF 0.19
Payout Frequency	Quarterly
Payout Ratio	24.77%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-34.85%
1Y total return	-39.8%
200-day SMA	74.29
3Y total return	-39.38%
50-day SMA	71.72
50-day SMA vs 200-day SMA	50under200
5Y total return	-55.48%
All Time High	160
All Time High Change	-59.38%
All Time High Date	2021-06-28
All Time Low	35
All Time Low Change	85.71%
All Time Low Date	2009-01-13
ATR	0.66
Beta	1.01
Ch YTD	-20.25
High52	119
High52 Date	2025-08-18
High52ch	-45.38%
Low52	64.5
Low52 Date	2026-05-06
Low52ch	0.78%
Ma50ch	-9.37%
Price vs 200-day SMA	-12.51%
RSI	24.11
RSI Monthly	29.45
RSI Weekly	33.33
Sharpe ratio	-1.12x
Sortino ratio	-1.07
Total Return	3.43%
Tr YTD	-20.02
Tr15y	27.97%
Tr1m	-10.34%
Tr3m	-4.85%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF 1.2B
Operating Income Growth	-4.58
Operating Income Growth Q	20.54
Operating Income Growth3 Y	2.05
Operating Income Growth5 Y	9.53
Operating margin	17.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	192,868,690%
Net Borrowing	111,881,520
Shares Insiders	0.18%
Shares Institutions	105.78%
Shares Qo Q	-1.16%
Shares Yo Y	-2.25%
Short Ratio	4.36

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF 838M
Average Volume	29.3x
Bv Per Share	52.56
CAPEX	CHF -428.5M
Ch10y	-41.76
Ch15y	9.89
Ch1m	-10.34
Ch1y	-40.37
Ch20y	-13.22
Ch3m	-5.11
Ch3y	-40.91
Ch5y	-58.6
Ch6m	-20.25
Change	0%
Close	65
Depreciation Amortization	861,953,877
Earnings Date	2026-04-28
EBIT	CHF 1.2B
EBITDA	CHF 2.1B
EPS	CHF 3.09
F Score	6
FCF	CHF 914M
FCF EV Yield	5.1x
Financing CF	-496,191,432
Fiscal Year End	December
Founded	1,927
Goodwill	7,716,561,669
Graham Number	62.04498
Graham Upside	-4.55
Income Tax	CHF 114.1M
Investing CF	-1,627,260,844
Is Primary Listing	0
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Lynch Fair Value	CHF 19.36
Lynch Upside	-70.21
Ma150	74.81
Ma150ch	-13.11%
Ma20	70.15
Ma20ch	-7.34%
Net CF	-770,275,836
P FCF Ratio	13.55
P OCF Ratio	9.22
Payment Date	2026-04-30
Ppne	1,718,391,373.5
Price Date	2026-05-08
Price EBITDA	CHF 5.98
Relative Volume	0.68x
Revenue	6,745,107,292x
SBC By Revenue	1.13x
Share Based Comp	76,040,976
Tax By Revenue	1.69x
Tax Rate	15.75%
Tr20y	1.06%
Tr6m	-19.84%
Z Score	2.55

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SWX/ZBH dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.2%

$0.77 annual per share

Payout ratio

+24.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-2.9%

0 consecutive years of growth

Total shareholder yield

+3.4%

Next ex-dividend date: 2026-03-31

Performance

SWX/ZBH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SWX/ZBH?

Insider, institutional, and short-interest positioning.

Institutional ownership

+105.8%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SWX/ZBH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

24.1

Below 30: short-term oversold

Price vs 200-day MA

-12.5%

50/200-day relationship not available

Beta (5Y)

1.01

Moves roughly with the market

Sharpe ratio

-1.12

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SWX/ZBH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current swx/ZBH stock rating?

swx/ZBH is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full swx/ZBH analysis?

The full report lives at /stocks/swx/ZBH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for swx/ZBH?

The latest report frames swx/ZBH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the swx/ZBH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.